tbuckley/cabot-search huggingface dataset:
Tacrolimus Plus High-Dose Dexamethasone Versus High-Dose Dexamethasone Alone As First-Line Treatment for Adult Immune Thrombocytopenia: The Phase 2, Open Label, Randomized Trial (TARGET 020)
Authors: Zhuo-Yu An, Ye-Jun Wu, Yun He, Xiao-Lu Zhu, Hong-Xia Shi, Chen-Cong Wang, Hao Jiang, Jin Lu, Qian Jiang, Qiu-Sha Huang, Hai-Xia Fu, Feng-Rong Wang, Xiao-Dong Mo, Yu Wang, Xiang-Yu Zhao, Yuan-Yuan Zhang, Wei Han, Huan Chen, Yao Chen, Chen-Hua Yan, Jing-Zhi Wang, Ting-Ting Han, Yu-Hong Chen, Yi-Fei Cheng, Ying-Jun Chang, Lan-Ping Xu, Kai-Yan Liu, Xiao-Jun Huang, Xiaohui Zhang
Journal: Blood (2021)
Error in Results Section of Abstract
Journal: JAMA Network Open (2021)

Eric M. Montminy, MD; Meijiao Zhou, PhD, MPH; Lauren Maniscalco, MPH; Harrison Penrose, MD, PhD; Timothy Yen, MD; Swati G. Patel, MD, MS; Xiao-Cheng Wu, MD, MPH; Jordan J. Karlitz, MD
Imposter Syndrome
Authors: Mustafa Husaini
Journal: JAMA Cardiology (2021)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Cardiology HomeNew OnlineCurrent IssueFor Authors Podcast Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Cardiology journal
Meet the First Authors
Authors: Justin Van, Daniel Gorski
Journal: Circulation Research (2021)

His research is focused on the interplay between innate immune cells, specifically monocytes and dendritic cells and the endothelium.His most recent work described how growth arrest specific-6 (GAS6) and Axl signaling coordinate a pro-inflammatory immune response to promote the development of hypertension and end-organ damage.Dr Van Beusecum's ongoing research employs approaches from human single cell sequencing to novel genetic mice to human subjects for investigating novel pathways of inflammation in hypertension.
Error in Affiliations
Authors: Edoardo Sciatti, Rossana Orabona
Journal: JAMA Cardiology (2021)

Liang Guo, PhD; Sho Torii, MD, PhD; Raquel Fernandez, BS; Ryan E. Braumann, BS; Daniela T. Fuller, BS; Ka-Hyun Paek, BS; Neel V. Gadhoke, BS; Kristin A. Maloney, MS, MGC; Kathryn Harris, MD; Christina M. Mayhew, BS; Roya Zarpak, MD, MS; Laura M. Stevens, PhD; Brady J. Gaynor, MS; Hiroyuki Jinnouchi, MD, PhD; Atsushi Sakamoto, MD, PhD; Yu Sato, MD; Hiroyoshi Mori, MD, PhD; Matthew D. Kutyna, MS; Parker J. Lee, BS; Leah M. Weinstein, BS; Carlos J. Collado-Rivera, MD; Bakr B. Ali, BS; Dheeraj R. Atmakuri, BS; Roma Dhingra; Emma L. B. Finn; Mack W. Bell, MD; Megan Lynch, BS; Anne Cornelissen, MD; Salome H. Kuntz, MD; Joo-Hyung Park, MD; Robert Kutys, MS; Ji-Eun Park, MD; Libin Wang, MD, PhD; Susie N. Hong, MD, MSc; Anuj Gupta, MD; Jennifer L. Hall, PhD; Frank D. Kolodgie, PhD; Maria E. Romero, MD; Linda J. B. Jeng, MD, PhD; Braxton D. Mitchell, PhD, MPH; Dipti Surve, MD; David R. Fowler, MD; Charles C. Hong, MD, PhD; Renu Virmani, MD; Aloke V. Finn, MD
Metabolism of tissue macrophages in homeostasis and pathology
Authors: Stefanie K. Wculek, Gillian Dunphy, Ignacio Heras-Murillo, Annalaura Mastrangelo, David Sancho
Journal: Cellular and Molecular Immunology (2021)

Abstract Cellular metabolism orchestrates the intricate use of tissue fuels for catabolism and anabolism to generate cellular energy and structural components. The emerging field of immunometabolism highlights the importance of cellular metabolism for the maintenance and activities of immune cells. Macrophages are embryo- or adult bone marrow-derived leukocytes that are key for healthy tissue homeostasis but can also contribute to pathologies such as metabolic syndrome, atherosclerosis, fibrosis or cancer. Macrophage metabolism has largely been studied in vitro. However, different organs contain diverse macrophage populations that specialize in distinct and often tissue-specific functions. This context specificity creates diverging metabolic challenges for tissue macrophage populations to fulfill their homeostatic roles in their particular microenvironment and conditions their response in pathological conditions. Here, we outline current knowledge on the metabolic requirements and adaptations of macrophages located in tissues during homeostasis and selected diseases.
Higher Efficacy of TBI + Cyclophosphamide Than TBI + Fludarabine As Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia: An Analysis By the Acute Leukemia Working Party of the EBMT
Authors: Sebastian Giebel, Myriam Labopin, Gerard Socie, Mahmoud Aljurf, Urpu Salmenniemi, Ibrahim Yakoub-Agha, Nicolaus Kröger, Mohsen Alzahrani, Bruno Lioure, Péter Reményi, Mutlu Arat, Jean-Henri Bourhis, Grzegorz Helbig, Abdelghani Tbakhi, Edouard Forcade, Helene Labussiere-Wallet, Anne Huynh, Eolia Brissot, Alexandros Spyridonidis, Bipin B. Savani, Zinaida Perić, Arnon Nagler, Mohamad Mohty
Journal: Blood (2021)
<i>Erratum:</i> Vol. 70, No. 37
Journal: MMWR Morbidity and Mortality Weekly Report (2021)

In the Surveillance Summary "Abortion Surveillance -United States, 2018," on page 5, the last sentence of the second paragraph should have read, "Overall, 0.9% of abortions were reported to CDC with unknown residence."On page 9, the fourth sentence of the first paragraph should have read, "Findings in this report on demographic characteristics of women seeking abortions were generally similar to previously published data from Guttmacher Institute's national survey of abortion patients in 2014, although the percentage of abortions accounted for by non-Hispanic Black women was lower and by Hispanic women was higher as compared with data provided to CDC (25)."
QOLP-05. HEALTH-RELATED QUALITY OF LIFE IN LOW-GRADE GLIOMA SURVIVORS 26 YEARS AFTER DIAGNOSIS
Authors: Florien Boele, Jaap Reijneveld, Philip de Witt Hamer, Hinke van Thuijl, Pieter Wesseling, Frank Lagerwaard, Martin Taphoorn, Mathilde Kouwenhoven, Tom Snijders, Linda Douw, Martin Klein
Journal: Neuro-Oncology (2021)

Abstract BACKGROUND Patients with low-grade gliomas (LGGs) often survive for many years, yet little is known about patients’ health-related quality of life (HRQOL) in long-term survivorship. We previously investigated HRQOL in LGG patients diagnosed on average 6 years prior to assessment (T1, N=195) with a follow-up in stable patients on average 12 years after diagnosis (T2, N=65). We present a final follow-up of LGG survivors (T3), now decades after diagnosis. METHODS Patients completed questionnaires to assess HRQOL (Short Form-36 Health Survey; EORTC-BN20), fatigue (Checklist Individual Strength (CIS)), and depressive symptoms (Center for Epidemiological Studies-Depression Scale (CES-D)). Changes over time (T1-T2-T3) on group level and participant level were assessed. RESULTS Of the 65 patients approached, 18 (27.7%) were deceased, 3 (4.6%) experienced tumour progression to WHO III, 7 (10.8%) declined, and 3 (4.6%) could not be contacted. Thirty-four patients (52.3%) participated (missing HRQOL data N=2; N=32 included in analysis). Survivors were M=52.0 (sd=11.3) years old and diagnosed M=26.2 (sd=3.7, range:19-35) years prior. On group level, a statistically significant (but not clinically relevant) improvement in mental health (p=0.049), and a clinically relevant (but not statistically significant) decline in emotional role functioning was found. Minimal detectable change in HRQOL scale scores over time was observed in individual participants (28.1% only improvement; 25.0% only decline; 21.9% both improvement and decline) with 25.0% remaining completely stable. At T3, 25.0% and 53.1% of survivors scored above the cut-off for high risk of depression (≥16 CES-D) and severe fatigue (≥35 CIS), respectively. CONCLUSION In LGG survivors, assessed decades after diagnosis and treatment, HRQOL does not appear to be greatly impacted during survivorship. However, depressive symptoms and fatigue remain relatively common. Findings can help inform patients, their families, and clinicians and can serve as a benchmark for treatment trials evaluating interventions that can have very long-term effects.
Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial
Authors: Arabella S V Stuart, Robert H Shaw, Xinxue Liu, Melanie Greenland, Parvinder K Aley, Nick J Andrews, J C Cameron, Sue Charlton, Elizabeth A Clutterbuck, Andrea M Collins, Tom Darton, Tanya Dinesh, Christopher J A Duncan, Anna England, Saul N Faust, Daniela M Ferreira, Adam Finn, Anna L Goodman, Christopher A Green, Bassam Hallis, Paul T Heath, Helen Hill, Bryn M Horsington, Teresa Lambe, Rajeka Lazarus, Vincenzo Libri, Patrick J Lillie, Yama F Mujadidi, Ruth Payne, Emma L Plested, Samuel Provstgaard-Morys, Maheshi N Ramasamy, Mary Ramsay, Robert C Read, Hannah Robinson, Gavin R Screaton, Nisha Singh, David P J Turner, Paul J Turner, Iason Vichos, Rachel White, Jonathan S Nguyen-Van-Tam, Matthew D Snape
Journal: The Lancet (2021)
Abstract 10368: The Safety and Tolerability of Prolonged Inhalation of Hydrogen Gas in Air: A Phase I Clinical Trial
Authors: Alexis Cole, Francesca Sperotto, Stephanie Carlisle-Larsen, Michael J Rivkin, James A Dinardo, John N Kheir
Journal: Circulation (2021)

Introduction: Ischemia reperfusion injury (IRI) is central to many critical illnesses, including cardiac arrest, myocardial infarction, and stroke. Inhaled hydrogen gas (H2) has been shown to diminish IRI in a number of preclinical models, in part by the selective reduction of oxyradical species. Methods: Following FDA and IRB approval of this Investigator-Initiated Phase I IND study (NCT04046211), 8 healthy participants underwent hospitalized exposure to 2.4% H2 in medical air via high flow nasal cannula (15 LPM) for either 24 hours (n=2), 48 hours (n=2), or 72 hours (n=4). Screening for adverse effects included periodic nurse-adjudicated assessments using Common Terminology Criteria for Adverse Events (CTCAE, v5.0); regularly-spaced vital signs, pulmonary function testing, and mini-mental state exam (MMSE); EKG and serologic testing prior to versus following exposure. Data were compared over time using Wilcoxon matched-pairs signed rank test. All AE assignments were verified by two clinicians external to the study team and an external DSMB. Results: Eight adult participants (18-30 years; 50% female; 62% non-Caucasian) completed the study without early termination. No symptoms or clinically significant adverse events occurred in any patient. Compared with baseline measures, there were no significant changes over time in blood pressure, heart rate, oxygen saturation, or respiratory rate (A). There were no significant changes in PFTs (B), MMSE scores (C), EKG measurements (D) or serologic tests for hematologic (except for clinically-insignificant increases in hematocrit and platelet counts), renal, hepatic, pancreatic, or cardiac injury (E) associated with H2 inhalation. Conclusion: Inhalation of 2.4% H2 gas does not appear to cause clinically significant adverse effects in healthy adults. These data will be foundational to future interventional studies of inhaled H2 in injury states, including following cardiac arrest.
Recommending Caution in Patient-Reported Outcome–Based Performance
Authors: Joseph Humphry
Journal: Annals of Internal Medicine (2021)

LettersDecember 2021Recommending Caution in Patient-Reported Outcome–Based PerformanceJoseph Humphry, MD, CPHIMSJoseph Humphry, MD, CPHIMSSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/L21-0635 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail TO THE EDITOR: I read Qaseem and colleagues' commentary (1) with interest. Rather than looking at patient-reported outcome–based performance measures as another layer of administrative burden for the practicing physician, the American College of Physicians needs to look at patient-reported outcomes as an alternative to existing measures. We need to focus on value-based care. Value is quality per cost. Porter (2) clearly defines health care value as “the health outcomes achieved per dollar spent.”The United States has built an industry around health care value metrics that is led by the National Committee for Quality Assurance and National Quality Forum. ...References1. Qaseem A, Tierney S, Barrett ED, et al; Performance Measurement Committee of the American College of Physicians. Recommending caution in patient-reported outcome–based performance measurement [Editorial]. Ann Intern Med. 2021;174:1161-2. [PMID: 33971097] doi:10.7326/M19-3603 LinkGoogle Scholar2. Porter ME. What is value in health care. N Engl J Med. 2010;363:2477-81. [PMID: 21142528] doi:10.1056/NEJMp1011024 CrossrefMedlineGoogle Scholar3. O’Kane M, Micciche F, Ryan B, et al. The future of healthcare quality. National Committee for Quality Assurance. 9 February 2021. Accessed at www.ncqa.org/videos/the-future-of-healthcare-quality on 20 October 2021. Google Scholar Author, Article, and Disclosure InformationAffiliations: Disclosures: The author has reported no disclosures of interest. The form can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=L21-0635. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoRecommending Caution in Patient-Reported Outcome–Based Performance Measurement Amir Qaseem , Samantha Tierney , Eileen D. Barrett , Catherine H. MacLean , Andrew Dunn , Nick Fitterman , and Recommending Caution in Patient-Reported Outcome–Based Performance Catherine H. MacLean , Samantha Tierney , Andrew Dunn , Eileen D. Barrett , Nick Fitterman , and Amir Qaseem Metrics December 2021Volume 174, Issue 12Page: 1778 ePublished: 21 December 2021 Issue Published: December 2021 Copyright & PermissionsCopyright © 2021 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...
Diagnostic Excellence
Authors: Daniel Yang, Harvey V. Fineberg, Karen Cosby
Journal: JAMA (2021)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Mitochondrial STAT3 exacerbates LPS-induced sepsis by driving CPT1a-mediated fatty acid oxidation
Authors: Rongqing Li, Xueqin Li, Jie Zhao, Fandong Meng, Chen Yao, Ensi Bao, Na Sun, Xin Chen, Wanpeng Cheng, Hui Hua, Xiangyang Li, Bo Wang, Hui Wang, Xiucheng Pan, Hongjuan You, Jing Yang, Takayuki Ikezoe
Journal: Theranostics (2021)

Rationale: We found that a subset of signal transducer and activator of transcription 3 (STAT3) translocated into mitochondria in phagocytes, including macrophages isolated from individuals with sepsis. However, the role of mitochondrial STAT3 in macrophages remains unclear. Method: To investigate the function of mitochondrial STAT3 in vivo, we generated inducible mitochondrial STAT3 knock-in mice. A cytokine array analysis, a CBA analysis, flow cytometry, immunofluorescence staining and quantification and metabolic analyses in vivo were subsequently performed in an LPS-induced sepsis model. Single-cell RNA sequencing, a microarray analysis, metabolic assays, mass spectrometry and ChIP assays were utilized to gain insight into the mechanisms of mitochondrial STAT3 in metabolic reprogramming in LPS-induced sepsis. Results: We found that mitochondrial STAT3 induced NF-κB nuclear localization and exacerbated LPS-induced sepsis in parallel with a metabolic switch from mainly using glucose to an increased reliance on fatty acid oxidation (FAO). Moreover, mitochondrial STAT3 abrogated carnitine palmitoyl transferase 1a (CPT1a) ubiquitination and degradation in LPS-treated macrophages. Meanwhile, an interaction between CPT1a and ubiquitin-specific peptidase 50 (USP50) was observed. In contrast, knocking down USP50 decreased CPT1a expression and FAO mediated by mitochondrial STAT3. The ChIP assays revealed that NF-κB bound the USP50 promoter. Curcumin alleviated LPS-mediated sepsis by suppressing the activities of mitochondrial STAT3 and NF-κB. Conclusion: Our findings reveal that mitochondrial STAT3 could trigger FAO by inducing CPT1a stabilization mediated by USP50 in macrophages, at least partially.
Elevation of activated neutrophils in chronic rhinosinusitis with nasal polyps
Authors: Julie A. Poposki, Aiko I. Klingler, Whitney W. Stevens, Lydia A. Suh, Bruce K. Tan, Anju T. Peters, Hiam Abdala-Valencia, Leslie C. Grammer, Kevin C. Welch, Stephanie S. Smith, David B. Conley, Robert C. Kern, Robert P. Schleimer, Atsushi Kato
Journal: Journal of Allergy and Clinical Immunology (2021)
Surplus sterols suppress <i>Salmonella</i> -specific IgA
Authors: Elise G. Liu, Stephanie C. Eisenbarth
Journal: Science Immunology (2021)

Dietary cholesterol is metabolized into 25-hydroxycholesterol, which decreases intestinal IgA responses by reducing the expression of sterol-sensing transcription factor SREBP2, thereby preventing IgA plasma cell differentiation.
Graphic Medicine—The Best of 2021
Authors: Michael J. Green, Brian Callender
Journal: JAMA (2021)

This Arts and Medicine feature reviews 2 outstanding graphic novels of 2021: Coma by Zara Slattery, about the author’s delirium while being treated for streptococcal sepsis and multiorgan failure, and Parenthesis by Élodie Durand, about her experience with tumor-induced seizures.
Misleading Reporting in Statistically Not Significant Oncology Trials—Joining Efforts Toward Unbiased Results Interpretation
Authors: Yichen Zhang, Xiaodong Guan
Journal: JAMA Network Open (2021)

Over the past decades, randomized clinical trials (RCTs) have gradually been accepted as the criterion standard to test the efficacy and safety of new treatments.Results from RCTs are widely used to inform regulatory approvals and clinical practices.To enable assessments of the validity of their results and conclusions, an RCT report should provide comprehensive information on its design, conduct, and analysis objectively.Previous approaches to reporting RCT results revealed many deficiencies, including a methodological discrepancy between noninferiority and superiority trials.
The OM-85 bacterial lysate inhibits SARS-CoV-2 infection of epithelial cells by downregulating SARS-CoV-2 receptor expression
Authors: Vadim Pivniouk, Oksana Pivniouk, Avery DeVries, Jennifer L. Uhrlaub, Ashley Michael, Denis Pivniouk, Sydney R. VanLinden, Michelle Y. Conway, Seongmin Hahn, Sean P. Malone, Peace Ezeh, Jared M. Churko, Dayna Anderson, Monica Kraft, Janko Nikolich-Zugich, Donata Vercelli
Journal: Journal of Allergy and Clinical Immunology (2021)
Sugar-Sweetened Beverage Taxes and Population Health Outcomes
Authors: Jennifer Falbe, Anna H. Grummon, James W. Krieger
Journal: JAMA Pediatrics (2021)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Pediatrics HomeNew OnlineCurrent IssueFor Authors Podcast Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Pediatrics journal
Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-controlled phase 3 trial
Authors: Scott A Halperin, Lingyun Ye, Donna MacKinnon-Cameron, Bruce Smith, Pedro E Cahn, Guillermo M Ruiz-Palacios, Aamer Ikram, Fernando Lanas, M Lourdes Guerrero, Sergio Raúl Muñoz Navarro, Omar Sued, Dmitry A Lioznov, Vitalina Dzutseva, Ghazala Parveen, Fengcai Zhu, Laura Leppan, Joanne M Langley, Luis Barreto, Jinbo Gou, Tao Zhu, Helen Mao, Luc Gagnon, Steven-Phay Tran, Sarwat Tahsin Khan, Amalia Guadalupe Becerra Aquino, Edgar Eduardo Saldaña Montemayor, Norma Eréndira Rivera Martínez, Víctor Casildo Bohórquez López, J. Abraham Simón Campos, Felipe de Jesús Pineda Cárdenas, Wei Chen, Lihua Hou, Zhe Zhang, Gonzalo Corral, Eduardo López, Ricardo Teijeiro, Maria F. Alzogaray, Cesar Zaidman, Gustavo Lopardo, Bernardo Goecke, Rosa María Feijooó Seoane, Sayed Faisal Mahmood, Ejaz Ahmed Khan, Jayed Akram, Salma Abbas, Naseem Salahuddin, Elena Rozhkova, Tatyana Zubkova
Journal: The Lancet (2021)